RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 90 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,041 | +46.8% | 2,968 | +5.6% | 0.00% | +100.0% |
| Q2 2023 | $46,353 | +32.5% | 2,811 | -7.4% | 0.00% | +100.0% |
| Q1 2022 | $34,975 | -53.5% | 3,036 | -59.7% | 0.00% | 0.0% |
| Q4 2021 | $75,189 | -34.5% | 7,534 | -14.3% | 0.00% | -50.0% |
| Q3 2021 | $114,837 | -52.9% | 8,793 | -29.4% | 0.00% | -33.3% |
| Q2 2021 | $243,771 | +19.2% | 12,450 | +29.5% | 0.00% | 0.0% |
| Q1 2021 | $204,511 | -31.9% | 9,615 | -4.8% | 0.00% | -25.0% |
| Q4 2020 | $300,332 | +37.2% | 10,102 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $218,910 | -2.8% | 10,102 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $225,275 | +46.5% | 10,102 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $153,752 | -29.0% | 10,102 | +7.0% | 0.00% | -25.0% |
| Q4 2019 | $216,674 | +23.2% | 9,437 | +15.9% | 0.00% | +33.3% |
| Q3 2019 | $175,829 | +54.0% | 8,144 | +56.9% | 0.00% | +50.0% |
| Q2 2019 | $114,202 | -7.5% | 5,191 | +15.3% | 0.00% | 0.0% |
| Q1 2019 | $123,400 | -8.6% | 4,502 | -10.3% | 0.00% | -33.3% |
| Q4 2018 | $134,938 | +5.8% | 5,020 | +14.8% | 0.00% | +50.0% |
| Q3 2018 | $127,560 | -34.9% | 4,373 | -35.3% | 0.00% | -33.3% |
| Q4 2017 | $196,000 | – | 6,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |